BIOA
BioAge LabsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The bullish view is that BGE-102's Phase 1 signal set already looks differentiated for an oral NLRP3 inhibitor, with management citing rapid biomarker reductions, tolerability, and two planned proof-of-concept trials that could turn BIOA into a multi-indication story if execution stays on track [#SEC-8K-2026-05-08].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.9.
What can break
Despite improved financing position after the follow-on offering, BIOA remains a clinical-stage biotech with ongoing cash burn and potential future dilution risk if timelines slip.
Momentum
94
Value
46
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $38.00 · Bear $14.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-26 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $49.50
Why
Momentum94 · Δ7d -3.9
Value46 · Δ7d +0.0
Sentiment54 · Δ7d +4.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
94
26% active weight
Current posture
7d trendFlat
Δ7d
-3.9
Δ21d
+0.3
Value
46
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
54
34% active weight
Current posture
7d trendImproving
Δ7d
+4.0
Δ21d
+53.1
Why this grade
Composite grade A. Momentum 94.0 / Value 46.4 / Sentiment 54.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$992.19M
Beta
-
Shares Out
44.45M
P/E (TTM) · Derived
-10.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-9.45
Rev YoY
+91.0%
EPS YoY
+45.3%
Gross Margin
+97.7%
Op Margin
-
Net Debt
-$275.54M
Current Ratio
24.76
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology